The pharmaceutical landscape is experiencing a change with the arrival of GLP-1 delivery devices. These innovative formulations offer a potential alternative to providing glucagon-like peptide-1 medication for individuals managing hyperglycemia. Instead of needles, a easy-to-use patch placed to the area could release a steady quantity of the treatm